Active collaboration

Discovering therapeutic antibodies designed by nature

Active collaboration for therapeutic antibody discovery

AIMM welcomes proposals from commercial partners interested in rapidly selecting rare antibodies from human patients or from immunized animals such as rabbits, llamas, or other mammalian species. This type of collaboration typically focuses on a single disease or pathogen and often includes sourcing antibodies from individual patients and a non-human species. Human samples may be sourced from key academic research hospitals or from tumor samples that may be part of a partner’s ongoing clinical trial.